A detailed history of Teachers Retirement System Of The State Of Kentucky transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Teachers Retirement System Of The State Of Kentucky holds 207,124 shares of DNLI stock, worth $5.01 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
207,124
Previous 207,124 -0.0%
Holding current value
$5.01 Million
Previous $4.81 Million 25.43%
% of portfolio
0.05%
Previous 0.04%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 28, 2024

SELL
$15.83 - $23.35 $24,061 - $35,492
-1,520 Reduced 0.73%
207,124 $4.25 Million
Q4 2023

Feb 26, 2024

SELL
$16.2 - $23.18 $154,710 - $221,369
-9,550 Reduced 4.38%
208,644 $4.48 Million
Q3 2023

Dec 13, 2023

SELL
$20.63 - $30.17 $25,870 - $37,833
-1,254 Reduced 0.57%
218,194 $4.5 Million
Q2 2023

Aug 21, 2023

SELL
$23.37 - $32.96 $47,955 - $67,633
-2,052 Reduced 0.93%
219,448 $6.48 Million
Q1 2023

May 11, 2023

BUY
$21.91 - $32.67 $328,650 - $490,050
15,000 Added 7.26%
221,500 $5.1 Million
Q4 2022

Feb 22, 2023

BUY
$26.28 - $33.92 $770,109 - $993,991
29,304 Added 16.54%
206,500 $5.74 Million
Q3 2022

Nov 22, 2022

BUY
$25.97 - $38.53 $148,029 - $219,621
5,700 Added 3.32%
177,196 $5.44 Million
Q3 2021

Nov 10, 2021

SELL
$48.48 - $78.23 $159,984 - $258,159
-3,300 Reduced 1.89%
171,496 $8.65 Million
Q2 2021

Jul 28, 2021

BUY
$50.3 - $78.44 $1.84 Million - $2.86 Million
36,500 Added 26.39%
174,796 $13.7 Million
Q1 2021

May 19, 2021

BUY
$53.8 - $81.53 $381,980 - $578,863
7,100 Added 5.41%
138,296 $7.9 Million
Q1 2020

Jul 16, 2020

BUY
$14.2 - $27.98 $1.86 Million - $3.67 Million
131,196 New
131,196 $2.3 Million

Others Institutions Holding DNLI

About Denali Therapeutics Inc.


  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.24B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Teachers Retirement System Of The State Of Kentucky Portfolio

Follow Teachers Retirement System Of The State Of Kentucky and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teachers Retirement System Of The State Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Teachers Retirement System Of The State Of Kentucky with notifications on news.